News

New pro-bono offering allows charities to access PHASTAR’s biometrics experts at no cost.

Think tank and survey results inform current DCT landscape.

Recent investments bring clinical trial technology platform to the fore.

Nabil Chehab, medical affairs head of lung cancer franchise at AstraZeneca, discuss strategies used in the Phase III AEGEAN trial for treating non-small lung cancer (NSCLC).

eDiary to help patients with seizure disorders and their caregivers self-monitor and manage their seizures.

Represents major upgrade of cloud native, AI-enabled Intelligence platform.

As part of the partnership, MLHUMC has joined the global network of partner hospitals on Clinerion’s Patient Network Explorer platform.

Calyx Medical Imaging will extend Neosoma's AI-based neuro-oncology software device to its customers.

Multichannel platform offers tracking for multiple recruitment sources.

Payments technology will be complimented by transportation, two-way messaging, and participant feedback.

Companies will apply machine learning and natural language processing to curate text fields.

The Intrepid Partner Program aims to accelerate the optimization of patient safety and health measurements in both clinical research and post market clinical care.

Offering includes pre-configured modules for patient recruitment, eligibility screening, enrollment, data capture, and participant engagement.

Offering now includes GLP/GCP compliant molecular and cell biology testing.

New platform will enable analytics and pattern recognition use cases on RWD across Clinerion's Patient Network Explorer network.

Move will add new global talent to Cytel’s Strategic Consulting group.

Partnership to connect recruitment and enrollment systems.

Intelligent functionality removes supply team burdens while ensuring drug availability and reducing waste.

Enhancements will help community research sites offer more clinical trials by streamlining trial matching with pharma sponsors.

Next Generation Sequencing (NGS) initiative improved the accuracy and speed of identifying cancer mutations in solid tumors.

Total Consent offering is an SaaS electronic consent management solution compatible with clinical trials in over 120 locales worldwide.

Combines Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.

Ten-year partnership will help Merck reduce operational costs and deliver value to patients, HCPs.

Deeper focus on patient engagement across the pharma/biotech product lifecycle.

Richard Williams, PhD, chief medical officer at Kinnate Biopharma Inc. discusses clinical trial strategies and challenges.

Suite includes DCT applications, an eCOA oncology library, and protocol design consulting.

Company exceeds enrollment goal for its AI platform.

Collaboration in EDC renewed for another five years.